GenMark Diagnostics (GNMK) stock price, revenue, and financials

GenMark Diagnostics market cap is $1.8 b, and annual revenue was $171.55 m in FY 2020

$1.8 B

GNMK Mkt cap, 26-Apr-2021

$171.6 M

GenMark Diagnostics Revenue FY, 2020
GenMark Diagnostics Gross profit (FY, 2020)67.9 M
GenMark Diagnostics Gross profit margin (FY, 2020), %39.6%
GenMark Diagnostics Net income (FY, 2020)-18.6 M
GenMark Diagnostics EBIT (FY, 2020)-11.1 M
GenMark Diagnostics Cash, 31-Dec-202040.6 M
GenMark Diagnostics EV1.8 B
Get notified regarding key financial metrics and revenue changes at GenMark DiagnosticsLearn more
Banner background

GenMark Diagnostics Revenue

GenMark Diagnostics revenue was $171.55 m in FY, 2020

Embed Graph

GenMark Diagnostics Income Statement

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q2, 2018Q3, 2018Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

901.0k1.3m2.2m3.6m5.3m11.1m5.2m4.6m7.9m6.6m6.3m10.1m7.6m8.5m11.1m12.5m10.8m12.5b12.4m11.6m14.9m15.8m18.4m20.9m38.7m40.1m

Cost of goods sold

1.3m1.8m1.7m2.2m3.0m5.0m3.2m4.1m3.7m3.2m2.7m4.0m3.3m3.4m4.4m4.7m4.4m6.4b7.5m7.4m10.5m10.2m11.8m13.9m22.6m24.2m

Gross profit

(393.0k)(469.0k)472.0k1.4m2.2m6.1m2.0m499.0k4.2m3.4m3.6m6.1m4.4m5.1m6.7m7.8m6.5m6.2b4.9m4.2m4.4m5.6m6.6m7.1m16.2m15.9m

Gross profit Margin, %

(44%)(36%)22%40%42%55%39%11%53%51%57%61%57%60%60%62%60%49%40%36%30%36%36%34%42%40%

Sales and marketing expense

1.2m1.3m1.4m1.4m1.5m2.4m2.6m4.9m3.0m3.4m3.2m3.7m3.7m3.6m3.7m3.3m3.2m4.7b5.2m5.1m5.2m5.4m5.8m6.3m6.1m6.3m

R&D expense

2.3m1.9m1.9m3.0m4.5m5.4m5.0m5.4m7.3m8.1m7.9m8.8m8.9m9.6m12.3m13.2m11.6m11.0b13.0m10.2m10.5m6.1m7.7m6.3m6.1m7.6m

General and administrative expense

1.8m2.4m2.6m2.6m2.5m2.6m2.5m2.5m2.8m3.1m2.8m3.7m3.7m3.1m3.4m3.9m3.2m4.0b4.0m3.6m4.5m4.7m4.9m4.8m8.9m4.6m

Operating expense total

5.3m5.6m6.0m7.0m8.5m10.3m10.1m12.8m13.1m14.6m13.9m16.1m16.3m16.2m19.4m20.4m18.1m19.7b22.2m18.9m20.2m16.2m18.5m17.3m21.2m18.5m

EBIT

(5.7m)(6.1m)(5.5m)(5.6m)(6.2m)(4.2m)(8.1m)(12.3m)(8.9m)(11.3m)(10.3m)(10.0m)(11.9m)(11.1m)(12.7m)(12.6m)(11.6m)(13.6b)(17.3m)(14.7m)(15.8m)(10.6m)(11.9m)(10.3m)(5.0m)(2.7m)

EBIT margin, %

(634%)(464%)(254%)(155%)(119%)(38%)(155%)(265%)(112%)(172%)(163%)(99%)(156%)(131%)(115%)(101%)(108%)(108%)(140%)(127%)(106%)(67%)(65%)(49%)(13%)(7%)

Interest expense

147.0k209.0k9.0k18.0k68.0k7.0k1.5m83.0k74.0k2.0k180.0k245.0k273.0k215.0k324.0k417.0k507.0m645.0k686.0k685.0k420.0k1.4m1.4m

Interest income

27.0k29.0k19.0k16.0k136.0k203.0k284.0k271.0k228.0k36.0k33.0k30.0k29.0k26.0k43.0k52.0m54.0k247.0k202.0k188.0k179.0k126.0k132.0k109.0k

Pre tax profit

(5.6m)(6.3m)(5.5m)(5.6m)(6.3m)(4.2m)(8.0m)(10.8m)(8.8m)(11.2m)(10.3m)(9.8m)(12.2m)(11.4m)(12.9m)(12.9m)(12.0m)(13.9b)(17.9m)(15.4m)(16.5m)(11.0m)(13.3m)(11.7m)(7.0m)(4.6m)

Income tax expense

12.0k(1.0k)32.0k(10.0k)1.0k7.0k1.0k23.0k6.0k19.0k(616.0k)22.0k(1.0k)4.0k35.0k(5.0k)14.0k1.0m77.0k9.0k34.0k5.0k45.0k(33.0k)15.0k63.0k

Net Income

(5.6m)(6.3m)(5.6m)(5.6m)(6.3m)(4.2m)(8.0m)(10.8m)(8.8m)(11.2m)(9.7m)(9.9m)(12.2m)(11.4m)(13.0m)(12.9m)(12.1m)(13.9b)(18.0m)(15.4m)(16.5m)(11.0m)(13.3m)(11.7m)(7.0m)(4.7m)

GenMark Diagnostics Balance Sheet

Annual

USDY, 2009Y, 2010Y, 2011FY, 2011Y, 2012FY, 2012Y, 2013FY, 2013FY, 2014Y, 2014FY, 2015Y, 2015FY, 2016FY, 2017FY, 2019FY, 2020

Cash

16.5m51.3m25.3m25.3m51.3m51.3m35.7m35.7m36.9m36.9m35.4m35.4m16.0m26.8m44.4m40.6m

Accounts Receivable

1.1m3.2m2.9m4.9m6.8m10.7m16.8m20.8m

Prepaid Expenses

322.0k226.0k552.0k575.0k591.0k1.8m1.9m2.7m

Inventories

2.2m2.0m2.1m2.1m2.1m2.1m3.1m3.1m3.1m10.9m11.3m21.3m

Current Assets

33.9m58.0m111.1m111.1m78.1m78.1m56.0m56.0m58.4m95.4m83.4m173.0m

PP&E

2.8m7.1m8.6m8.6m11.1m11.1m11.4m11.4m18.3m22.6m20.4m38.4m

Total Assets

38.2m68.0m121.8m121.8m92.0m92.0m70.7m70.7m80.3m121.6m111.5m223.5m

Accounts Payable

1.2m2.4m3.9m3.9m3.5m3.5m4.4m4.4m4.4m11.2m12.2m23.1m

Short-term debt

1.0m638.0k37.0k373.0k7.9m

Current Liabilities

6.4m9.2m10.2m10.2m12.3m12.3m10.6m10.6m26.4m27.7m24.3m44.1m

Long-term debt

585.0k9.9m20.1m74.9m84.0m

Non-Current Liabilities

241.0k53.0k

Total Debt

1.0m1.2m37.0k10.3m28.0m74.9m84.0m

Total Liabilities

7.6m11.6m12.6m13.9m22.1m51.1m99.3m129.3m

Common Stock

2.0k3.0k4.0k4.0k4.0k6.0k6.0k7.0k

Preferred Stock

Additional Paid-in Capital

199.5m247.4m333.4m333.4m340.5m340.5m353.2m353.2m393.3m487.5m526.3m626.8m

Retained Earnings

(168.5m)(190.6m)(224.2m)(224.2m)(262.5m)(262.5m)(304.7m)(304.7m)(355.3m)(417.1m)(514.2m)(532.9m)

Total Equity

30.6m56.5m109.2m78.0m48.6m48.6m38.2m70.4m12.2m94.2m

Debt to Equity Ratio

0.4 x

Debt to Assets Ratio

0.2 x

Financial Leverage

1.2 x1.2 x1.1 x1.2 x1.5 x1.5 x2.1 x1.7 x9.2 x2.4 x

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q2, 2018Q3, 2018Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Cash

43.5m31.0m23.8m64.2m53.4m32.0m18.8m63.3m27.9m26.8m25.7m36.9m32.1m34.2m27.9m29.6m19.3m13.2m88.4m27.2m28.9m25.0m23.7m24.3m26.3m82.4m57.8m

Accounts Receivable

640.0k724.0k1.1m1.3m1.2m4.4m4.4m2.4m2.6m2.1m2.7m4.4m4.3m5.4m5.4m5.1m7.3m7.8m7.1m9.9m6.8m10.4m25.7m17.9m16.2m

Prepaid Expenses

495.0k428.0k135.0k192.0k183.0k382.0k772.0k682.0k627.0k1.1m1.2m770.0k874.0k623.0k1.3m1.2m1.3m2.0m1.9m1.9m2.1m2.1m1.8m1.8m2.8m

Inventories

1.2m2.0m2.1m1.9m2.1m3.2m3.4m2.0m1.8m1.2m1.5m2.1m2.0m2.7m2.4m2.6m4.2m9.0m7.1m7.1m8.8m11.3m9.9m12.6m9.9m14.9m19.6m

Current Assets

45.9m39.1m27.1m67.6m60.4m52.8m45.1m117.5m102.6m93.8m84.7m78.3m69.1m62.1m46.5m46.8m64.7m42.1m122.2m103.8m73.1m65.7m60.1m58.3m84.5m167.4m175.9m

PP&E

3.2m3.1m3.4m4.2m5.2m7.3m8.1m7.9m9.6m9.9m10.2m11.4m11.8m11.6m11.7m12.7m17.3m18.5m19.8m21.6m21.2m21.9m18.9m18.9m19.6m19.4m26.2m

Total Assets

50.5m43.7m32.3m73.5m68.6m63.8m56.9m128.6m114.2m106.6m97.7m92.3m83.6m77.1m61.4m62.6m85.7m64.1m145.9m129.1m97.9m91.0m87.2m85.1m111.6m195.0m214.6m

Accounts Payable

2.9m1.5m1.7m1.6m2.4m2.3m2.1m3.0m3.8m3.3m3.3m3.4m4.1m4.9m5.1m6.1m5.4m5.7m6.7m7.2m9.2m8.2m8.4m10.0m10.3m15.4m21.2m

Short-term debt

917.0k1.0m1.0m1.0m852.0k353.0k251.0k111.0k2.9m5.4m19.3m19.5m19.0m5.3m1.9m2.7m

Current Liabilities

6.6m6.4m5.4m6.7m7.7m8.0m7.7m8.4m10.1m11.7m11.6m9.6m9.3m11.5m11.5m15.9m19.8m34.0m34.9m35.8m17.5m17.7m21.6m26.8m29.1m40.7m

Long-term debt

335.0k9.8m9.6m16.7m14.3m14.9m9.9m9.6m28.7m54.6m54.8m71.7m75.4m79.7m

Total Debt

917.0k1.0m1.0m1.0m852.0k688.0k251.0k111.0k9.8m9.6m19.7m19.7m34.2m29.5m28.6m28.7m48.3m48.7m77.0m77.3m82.4m

Total Liabilities

8.8m7.9m6.5m7.7m8.5m10.3m10.0m10.7m12.4m14.0m13.2m20.8m20.6m22.8m22.7m34.2m38.1m37.0m52.5m48.5m48.3m49.3m72.4m76.5m98.6m104.8m120.6m

Common Stock

2.0k2.0k2.0k3.0k3.0k3.0k3.0k4.0k4.0k4.0k4.0k4.0k4.0k4.0k4.0k5.0k6.0k5.0k6.0k6.0k6.0k6.0k6.0k7.0k7.0k

Preferred Stock

Additional Paid-in Capital

199.0m199.3m200.3m245.9m246.4m248.7m250.0m331.9m334.8m336.9m338.4m343.9m347.5m350.1m356.3m358.9m390.2m396.2m480.5m483.2m493.9m497.0m506.9m512.5m534.2m616.0m623.0m

Retained Earnings

(156.7m)(163.0m)(174.0m)(179.6m)(185.9m)(194.7m)(202.8m)(213.6m)(233.0m)(244.2m)(253.9m)(272.3m)(284.5m)(295.9m)(317.6m)(330.5m)(342.6m)(369.2m)(387.2m)(402.6m)(444.3m)(455.3m)(492.3m)(503.9m)(521.2m)(525.9m)(529.2m)

Total Equity

41.7m35.8m25.8m65.8m60.1m53.5m46.8m117.9m101.8m92.7m84.6m71.6m63.0m54.2m38.7m28.4m47.6m27.1m93.4m80.6m49.6m41.7m14.8m8.6m13.0m90.2m94.0m

Debt to Equity Ratio

0.6 x0.7 x3.3 x5.7 x

Debt to Assets Ratio

0.3 x0.3 x0.6 x0.6 x

Financial Leverage

1.2 x1.2 x1.3 x1.1 x1.1 x1.2 x1.2 x1.1 x1.1 x1.2 x1.2 x1.3 x1.3 x1.4 x1.6 x2.2 x1.8 x2.4 x1.6 x1.6 x2 x2.2 x5.9 x9.9 x8.6 x2.2 x2.3 x

GenMark Diagnostics Cash Flow

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2019FY, 2020

Net Income

(24.0m)(22.1m)(33.6m)(38.3m)(42.2m)(50.6m)(61.8m)(47.3m)(18.6m)

Depreciation and Amortization

1.3m1.2m2.5m2.7m3.4m3.9m5.3m7.3m7.1m

Accounts Receivable

(420.0k)(2.1m)(2.4m)(2.0m)(2.0m)(2.2m)(1.6m)(5.6m)(4.1m)

Inventories

(1.7m)(880.0k)(1.3m)(229.0k)(1.3m)(3.4m)(10.5m)(6.5m)(12.5m)

Accounts Payable

378.0k728.0k1.3m85.0k(757.0k)4.1m2.6m1.5m5.2m

Cash From Operating Activities

(19.2m)(16.2m)(23.8m)(29.6m)(31.9m)(35.6m)(53.4m)(34.9m)6.1m

Purchases of PP&E

(1.4m)(3.5m)(4.3m)(5.7m)(3.8m)(7.0m)(4.8m)(2.1m)(17.8m)

Cash From Investing Activities

(7.1m)(2.1m)(72.6m)29.4m19.3m(24.1m)(24.9m)(2.2m)(96.5m)

Long-term Borrowings

(417.0k)(2.0m)(766.0k)(56.0k)(22.0k)(57.0k)

Cash From Financing Activities

33.3m44.3m80.8m1.3m11.1m40.4m89.1m45.2m87.6m

Net Change in Cash

7.0m25.9m(15.5m)1.1m(1.5m)10.8m8.1m(2.9m)

Interest Paid

95.0k90.0k19.0k20.0k572.0k1.1m1.6m3.9m5.7m

Income Taxes Paid

91.0k21.0k24.0k10.0k65.0k61.0k155.0k91.0k

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q2, 2017Q3, 2017Q2, 2018Q3, 2018Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Net Income

(12.2m)(18.5m)(5.6m)(11.2m)(17.4m)(4.2m)(12.2m)(23.0m)(8.8m)(20.0m)(29.7m)(9.9m)(33.4m)(13.0m)(25.9m)(37.9m)(25.4m)(37.1m)(7.0m)

Depreciation and Amortization

622.0k948.0k264.0k576.0k918.0k498.0k1.0m1.9m574.0k1.2m1.9m797.0k2.7m900.0k1.8m2.7m2.5m3.8m3.5m5.3m3.6m5.4m1.8m3.5m5.4m

Accounts Receivable

38.0k(46.0k)72.0k(170.0k)(9.0k)(1.2m)(1.5m)(1.9m)283.0k731.0k151.0k445.0k557.0k1.4m1.4m(1.7m)1.8m1.3m(3.5m)797.0k4.7m993.0k(9.0m)(1.9m)376.0k

Inventories

(275.0k)(1.4m)757.0k1.1m(402.0k)(1.5m)(1.8m)(216.0k)169.0k608.0k209.0k(366.0k)(980.0k)501.0k306.0k1.0m(2.6m)(4.8m)(353.0k)(3.8m)(1.4m)(5.5m)920.0k(5.0m)(10.2m)

Accounts Payable

1.4m510.0k(112.0k)369.0k907.0k129.0k(310.0k)570.0k(449.0k)(501.0k)(318.0k)(775.0k)(358.0k)617.0k1.3m916.0k(3.1m)(1.5m)(1.9m)(3.4m)(1.1m)345.0k(1.6m)3.6m7.4m

Cash From Operating Activities

(8.0m)(14.0m)(5.5m)(8.7m)(12.5m)(6.1m)(13.3m)(17.5m)(6.4m)(13.5m)(22.2m)(8.3m)(23.7m)(6.0m)(15.5m)(25.2m)(28.2m)(40.6m)(16.4m)(28.9m)(15.6m)(25.6m)(7.6m)385.0k6.7m

Purchases of PP&E

(609.0k)(1.2m)(17.0k)(1.5m)(2.9m)(1.0m)(2.2m)(3.3m)(1.1m)(2.6m)(3.7m)(411.0k)(2.9m)(966.0k)(2.4m)(5.1m)(2.5m)(3.8m)(924.0k)(1.1m)(467.0k)(1.2m)(952.0k)(1.7m)(7.9m)

Cash From Investing Activities

(974.0k)(6.9m)4.2m2.7m(3.8m)(12.9m)(19.0m)(51.4m)(1.4m)4.1m11.6m(1.2m)10.4m(1.8m)(1.1m)(30.7m)5.0m(38.4m)18.1m26.7m(9.1m)(1.0m)(12.7m)(43.0m)(78.4m)

Long-term Borrowings

(167.0k)(267.0k)(521.0k)(1.6m)(287.0k)(561.0k)(706.0k)(42.0k)(46.0k)(51.0k)(5.0k)(15.0k)(5.0k)(17.0k)(28.0k)(964.0k)(6.1m)(45.0k)(68.0k)(35.1m)(35.1m)(23.0k)(33.0k)(45.0k)

Cash From Financing Activities

34.2m33.6m(267.0k)44.9m44.4m(182.0k)(117.0k)80.9m(17.0k)507.0k523.0k9.5m10.7m330.0k10.8m39.8m95.7m90.3m492.0k469.0k12.2m14.6m2.1m81.5m86.0m

Net Change in Cash

25.2m12.7m(1.5m)38.9m28.1m(19.2m)(32.4m)12.0m(7.8m)(8.9m)(10.1m)58.0k(2.6m)(7.5m)(5.8m)(16.1m)72.5m11.2m2.1m(1.7m)(12.6m)(12.0m)(18.1m)38.9m14.3m

Interest Paid

7.0k14.0k17.0k1.0k4.0k18.0k73.0k607.0k184.0k408.0k761.0k574.0k1.1m1.0m1.5m1.8m2.9m1.5m3.1m4.6m

Income Taxes Paid

6.0k8.0k8.0k26.0k27.0k17.0k9.0k13.0k13.0k38.0k54.0k58.0k113.0k133.0k104.0k85.0k19.0k48.0k94.0k

GenMark Diagnostics Ratios

USDY, 2009

GenMark Diagnostics Operating Metrics

FY, 2014FY, 2015FY, 2016

Patents Issued

130120100

Patents Pending

253530

GenMark Diagnostics Employee Rating

3102 votes
Culture & Values
2.8
Work/Life Balance
2.9
Senior Management
2.5
Salary & Benefits
3
Career Opportunities
2.9
Source